International Conference on Drug Discovery and Lead Optimization

The International Conference on Drug Discovery and Lead Optimization, organized by the USG United Scientific Group, is set to take place at the Crowne Plaza San Francisco Airport in Burlingame, California. This annual event serves as a crucial platform for over 150 attendees, including researchers, industry professionals, and academics, to explore and share insights into advancements in drug discovery and lead optimization. The conference aims to address a spectrum of topics essential for developing new medications for various diseases, including chronic and infectious conditions.

As we celebrate the Tenth edition of this prominent conference, attendees will benefit from a diverse program featuring key speakers from notable institutions such as the University of Missouri Cancer Nanotechnology, Hebei University of Technology in China, and Aviceda Therapeutics Inc. Attendees can look forward to engaging sessions on cutting-edge themes such as the advancements in AI for drug development, the application of large language models (LLMs) in drug discovery, and the computer-aided design of new molecules.

Furthermore, the conference will delve into significant areas like cancer therapeutic and diagnostic applications, RNA-based therapeutics, vaccines, and biologics, as well as discussions on investment, commercialization, and market access. Participants will have access to all talks and poster sessions, as well as a free conference app to enhance their experience.

Overall, Drug Discovery-2026 is dedicated to fostering an environment conducive to exchanging the latest research results and sharing advanced research methodologies.